Sign in
CompletedNo phase

Microcirculation and Coagulopathy in Sepsis

Key facts

Who runs it
Università Politecnica delle Marche
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
1 Jun 2023
Ended
30 Jun 2025
Type of study
Observational
Record updated
11 February 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • adult (>18 years of age)
  • sepsis or septic shock

Who cannot take part

  • concurrent use of therapeutic anticoagulation or thrombolytic agents
  • sepsis for more than 24 hours
  • pre-existing coagulopathy
  • factors impeding the sublingual microvascular assessment
  • pregnancy
  • inability to obtain informed consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sepsis-induced coagulopathy (SIC) and microvascular dysfunction are hallmark features of sepsis, yet their longitudinal relationship remains poorly understood. The aim of this study is to investigate the interplay between sublingual microcirculation, endothelial damage, peripheral tissue oxygenation and coagulation parameters in patients with sepsis.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Relationship Between Microcirculatory Alterations and Coagulopathy in Sepsis: Prospective Observational Study.
Record updated
11 February 2026